139 related articles for article (PubMed ID: 361314)
1. Complement-mediated immune mechanisms in renal infection. II. Effect of decomplementation.
Miller TE; Phillips S; Simpson IJ
Clin Exp Immunol; 1978 Jul; 33(1):115-21. PubMed ID: 361314
[TBL] [Abstract][Full Text] [Related]
2. [Defense mechanisms of the macro-organism in bacteriuria in chronic pyelonephritis].
Falkenhagen U; Wendt M; Hilbert R; Zingler G
Z Urol Nephrol; 1986 Nov; 79(11):619-27. PubMed ID: 3551386
[TBL] [Abstract][Full Text] [Related]
3. Studies of the mechanism of bacterial resistance to complement-mediated killing. V. IgG and F(ab')2 mediate killing of E. coli 0111B4 by the alternative complement pathway without increasing C5b-9 deposition.
Joiner KA; Goldman RC; Hammer CH; Leive L; Frank MM
J Immunol; 1983 Nov; 131(5):2563-9. PubMed ID: 6355296
[TBL] [Abstract][Full Text] [Related]
4. Effects of decomplementation on mercuric chloride-induced glomerulonephritis in Brown-Norway rats.
Capron M; Bascou C; Vial MC; Grossetete J; Hinglais N; Girard JF; Druet P
Clin Exp Immunol; 1982 Sep; 49(3):611-7. PubMed ID: 6216993
[TBL] [Abstract][Full Text] [Related]
5. [Serum resistance of Escherichia coli and serum bactericidal activity in chronic pyelonephritis].
Falkenhagen U; Handschuck I; Nimmich W; Zingler G; Naumann G
Z Urol Nephrol; 1984 Nov; 77(11):629-38. PubMed ID: 6395557
[TBL] [Abstract][Full Text] [Related]
6. [Serum resistance of Escherichia coli in chronic pyelonephritis. 1. Serum resistance in the human serum pool].
Falkenhagen U; Handschuck I; Ulisko IN; Ratiner YuA ; Nimmich W; Zingler G; Naumann G
Z Urol Nephrol; 1984 Jul; 77(7):391-400. PubMed ID: 6385542
[TBL] [Abstract][Full Text] [Related]
7. Studies on the mechanism of bacterial resistance to complement-mediated killing. VI. IgG increases the bactericidal efficiency of C5b-9 for E. coli 0111B4 by acting at a step before C5 cleavage.
Joiner KA; Goldman RC; Hammer CH; Leive L; Frank MM
J Immunol; 1983 Nov; 131(5):2570-5. PubMed ID: 6355297
[TBL] [Abstract][Full Text] [Related]
8. Experimental Escherichia coli 06 infection in mice. IV. On the relative importance of complement factors and antibodies for the host defence.
Ahlstedt S
Acta Pathol Microbiol Scand C; 1981 Feb; 89(1):23-8. PubMed ID: 7027735
[TBL] [Abstract][Full Text] [Related]
9. The effect of complement depletion on the course of Sindbis virus infection in mice.
Hirsch RL; Griffin DE; Winkelstein JA
J Immunol; 1978 Oct; 121(4):1276-8. PubMed ID: 701795
[TBL] [Abstract][Full Text] [Related]
10. Anti-capsular antibodies activate killing of Escherichia coli O8:K87 by the alternate complement pathway in porcine serum.
Clark NM; Berberov EM; Wang M; Moxley RA
Vet Immunol Immunopathol; 2006 Nov; 114(1-2):185-91. PubMed ID: 16919781
[TBL] [Abstract][Full Text] [Related]
11. The effects of cobra venom factor, an inhibitor of the complement system, on the sequence of morphological events in the rat kidney in experimental pyelonephritis.
Sullivan MJ; Harvey RA; Shimamura T
Yale J Biol Med; 1977; 50(3):267-73. PubMed ID: 329591
[TBL] [Abstract][Full Text] [Related]
12. The classical complement pathway plays a critical role in the opsonisation of uropathogenic Escherichia coli.
Li K; Sacks SH; Sheerin NS
Mol Immunol; 2008 Feb; 45(4):954-62. PubMed ID: 17870166
[TBL] [Abstract][Full Text] [Related]
13. Interaction of turkey complement with Escherichia coli isolated from turkeys.
Ellis MG; Arp LH; Lamont SJ
Am J Vet Res; 1989 Aug; 50(8):1285-9. PubMed ID: 2675694
[TBL] [Abstract][Full Text] [Related]
14. [Effect of immunization with Escherichia coli J5 on the course of experimental pyelonephritis in rats].
Straube E; Naumann G; Broschewitz U
Z Urol Nephrol; 1988 Apr; 81(4):247-55. PubMed ID: 3041706
[TBL] [Abstract][Full Text] [Related]
15. Complement-mediated immune mechanisms in renal infection.
Ormrod DJ; Miller TE
Clin Exp Immunol; 1978 Jul; 33(1):107-14. PubMed ID: 709907
[TBL] [Abstract][Full Text] [Related]
16. Role of complement in chemotaxis: study of a localized infection.
Wilson DM; Ormrod DJ; Miller TE
Infect Immun; 1980 Jul; 29(1):8-12. PubMed ID: 6995344
[TBL] [Abstract][Full Text] [Related]
17. Immunological enhancement in the pathogenesis of pyelonephritis.
Miller TE; Burnham S; North JD
Clin Exp Immunol; 1976 May; 24(2):336-45. PubMed ID: 776466
[TBL] [Abstract][Full Text] [Related]
18. Deficient serum bactericidal activity against Escherichia coli in patients with cirrhosis of the liver.
Fierer J; Finley F
J Clin Invest; 1979 May; 63(5):912-921. PubMed ID: 376551
[TBL] [Abstract][Full Text] [Related]
19. The interaction of Escherichia coli with normal human serum: the kinetics of serum-mediated lipopolysaccharide release and its dissociation from bacterial killing.
Tesh VL; Duncan RL; Morrison DC
J Immunol; 1986 Aug; 137(4):1329-35. PubMed ID: 3525676
[TBL] [Abstract][Full Text] [Related]
20. Protection against experimental pyelonephritis by antibodies to pili.
Silverblatt FJ; Weinstein R; Rene P
Scand J Infect Dis Suppl; 1982; 33():79-82. PubMed ID: 6127805
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
